Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. GeneSilico
BrandsGeneSilico

How AI describes GeneSilico

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

GeneSilico logoGeneSilicogenesilico.ai · Evidence updating
Evidence updating

GeneSilico provides an AI-powered platform that builds a patient-specific cancer Digital Twin to simulate tumor response and resistance to all treatment options before dosing. It offers a suite of AI agents and a unified Oncology Clinical Control Plane that orchestrates care, integrates with EHRs, and ranks therapies based on digital twin predictions. It also enables AI-driven drug discovery and continuous, point-of-care evidence generation across hospitals and CRO networks, delivering auditable efficacy data from molecule to patient.

Parse Score

—

Work at GeneSilico?

Claim this profile for the full report: every prompt where GeneSilico appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor GeneSilico

Sources

genesilico.ai shapes more of what AI says about GeneSilico than any other source, at 67% of its citations.

precision-ai.com

AI questions where GeneSilico appears

Prompt
Prompt visibility
Which startups help doctors use patient-specific diagnostics to choose treatments earlier?2.8

Always know where you stand in AI

Start monitoring GeneSilico